Browse > Article

Vasorelaxant effect of fluoxetine in isolated rat aorta  

Kim, Shang-Jin (Bio-Safety Research Institute, Chonbuk National University)
Kang, Hyung-sub (Bio-Safety Research Institute, Chonbuk National University)
Kim, Jin-shang (Bio-Safety Research Institute, Chonbuk National University)
Publication Information
Korean Journal of Veterinary Research / v.44, no.4, 2004 , pp. 515-522 More about this Journal
Abstract
The vasorelaxant effect of serotonin reuptake inhibitor fluoxetine was investigated in rat isolated thoracic aorta. Fluoxetine induced a concentration-dependent relaxation in aorta precontracted with phenylephrine (PE) and KCl. These relaxations were suppressed by removal of the endothelium (-E) or pretreatment of nitric oxide synthase inhibitors, N(G)-nitro-L-arginine (L-NNA) and N(omega)-nitro-Larginine methyl ester (L-NAME), guanylate cyclase inhibitors, methylene blue (MB) and 1H-[1,2,4]oxadiazolo [4,3-a]quinoxalin-1-one (ODQ), and $Ca^{2+}$ channel blockers, nifedipine and verapamil, in PE-precontracted +E rings. However, fluoxetine-induced relaxations were not suppressed by pretreatment of $K^{+}$ channel blockers, tetrabutylammonium and glibenclamide, in PE-precontracted endothelium intact (+E) rings. The fluoxetine-induced relaxations were not suppressed by removal of the endothelium or pretreatment of LNNA and MB in KCl-precontracted +E rings. Also, fluoxetine inhibited PE-induced sustained contraction in +E rings. These inhibitory effects of fluoxetine on contractions could be reversed by removal of the endothelium or pretreatment of L-NNA, L-NAME, MB, ODQ, nifedipine and verapamil, but not by pretreatment of etrabutylammonium and glibenclamide. These findings suggest that the vasorelaxant effect of fluoxetine is modulated by intracellular $Ca^{2+}$ with an involvement of endothelial NO-cGMP pathway and also may be related to the inhibition of $Ca^{2+}$ entry through voltage-gated channel.
Keywords
fluoxetine; endothelium; relaxation; $Ca^{2+}$ channel; rat; aorta;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Brayden, J. E. Potassium channels in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol. 1996, 23, 1069-1076
2 Glusa, E. and Pertz, H. H. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors. Br. J. Pharmacol. 2000, 130, 692-698
3 Jagadesh, S. R. and Subhash, M. N. Effect of antidepressants on intracellular $Ca^{2+}$ mobilization in human frontal cortex. Biol. Psychiatery. 1998, 44, 617-621
4 Tuladhar, B. R., Costall, B. and Naylor, R. J. Pharmacological characterization of the 5-hydroxytryptamine receptor mediating relaxation in the rat isolated ileum. Br. J. Pharmacol. 1996, 119, 303-310
5 Li, Q., Brownfield, M. S., Battaglia, G., Cabrera, T. M., Levy, A. D., Rittenhouse, P. A. and van de Kar, L. D. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). J. Pharmacol. Exp. Ther. 1993, 266, 836-844
6 Ni, Y. G. and Miledi, R. Blockage of 5-$HT_{2C}$ serotonin receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. USA. 1997, 94, 2036-2040
7 Somlyo, A. P. and Himpens, B. Cell calcium and its regulation in smooth muscle. FASEB J. 1989, 3, 2266-2276
8 Nakajima, T., Hazama, H., Hamada, E., Wu, S. N., Igarashi, K., Yamashita, T., Seyama, Y., Omata, M. and Kurachi, Y. Endothelin-1 and vasopressin activate Ca(2+)-permeable non-selective cation channels in aortic smooth muscle cells: mechanism of receptormediated $Ca^{2+}$ influx. J. Mol. Cell Cardiol. 1996, 28, 707-722
9 Lavoie, P. A., Beauchamp, G. and Elie, R. Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes. Can. J. Physiol. Pharmacol. 1997, 75, 983-987
10 Villazon, M., Padin, J. F., Cadavid, M. I., Enguix, M, J., Tristan, H., Orallo, F. and Loza, M. I. Functional characterization of serotonin receptors in rat isolated aorta. Biol. Pharm. Bull. 2002, 25, 584-590
11 Terron, J. A. Antagonism of the relaxant 5-HT receptor in the dog basilar artery by the high-affinity 5-$HT_7$ receptor ligand, LY215840. Proc. West Pharmacol. Soc. 1998, 41, 129-130
12 Ellis, E. S., Byrne, C., Murphy, O. E., Tilford, N. S. and Baxter, G. S. Mediation by 5-hydroxytryptamine 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br. J. Pharmacol. 1995, 114, 400-404
13 Busch, L., Wald, M., Sterin-Borda, L. and Borda, E. Fluoxetine modulates norepinephrine contractile effect on rat vas deferens. Pharmacol. Res. 2000, 41, 39-45
14 Huang, Y. Inhibitory effect of noradrenalin uptake inhibitors on contractions of rat aortic smooth muscle. Br. J. Pharmacol. 1996, 117, 533-539
15 Pitt, B. R., Weng, W., Steve, A. R., Blakely, R. D., Reynolds, I. and Davies, P. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am. J. Physiol. 1994, 266, L178-186
16 Carvajal, J. A., Germain, A. M., Huidobro-Toro, J. P. and Weiner, C. P. Molecular mechanism of cGMPmediated smooth muscle relaxation. J. Cell Physiol. 2000, 184, 409-420
17 Pacher, P., Ungvari, Z., Kecskemeti, V. and Koller, A. Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered $Ca^{2+}$ sensitivity. Br. J. Pharmacol. 1999, 127, 740-746
18 Terron, J. A. and Falcon-Neri, A. Pharmacological evidence for the 5-$HT_7$ receptor mediating smooth muscle relaxation in canine cerebral arteries. Br. J. Pharmacol. 1999, 127, 609-616
19 Reeves, J. J., Bunce, K. T. and Humphrey, P. P. Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus. Br. J. Pharmacol. 1991, 103, 1067-1072
20 Velasco, A., Alamo, C., Hervas, J. and Carvajal, A. Effects of fluoxetine hydrochloride and fluvoxamine maleate on different preparations of isolated guinea pig and rat organ tissues. Gen. Pharmacol. 1997, 28, 509-512
21 Hudgins, P. M. and Weiss, G. B. Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. J. Pharmacol. Exp. Ther. 1968, 159, 91-97
22 Pacher, P., Ungvari, Z., Kecskemeti, V., Friedmann, T. and Furst, S. Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle. Can. J. Physiol. Pharmacol. 2001, 79, 580-584
23 Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M., Amano, K., Harada, K., Miyamoto, S., Nakazawa, H., Won, K. J. and Sato, K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 1997, 49, 157-230
24 Ungvari, Z., Pacher, P., Kecskemeti, V. and Koller, A. Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener. Stroke. 1999, 30, 1949-1954
25 Lucchelli, A., Santagostino-Barbone, M. G., Masoero, E., Baiardi, P. and Tonini, M. Influence of fluoxetine and litoxetine on 5-$HT_4$ receptor-mediated relaxation in the rat isolated oesophagus. Fundam. Clin. Pharmacol. 1999, 13, 330-336
26 Taggart, M. J., Menice, C. B., Morgan, K. G. and Wray, S. Effect of metabolic inhibition on intracellular $Ca^{2+}$, phosphorylation of myosin regulatory light chain and force in rat smooth muscle. J. Physiol. 1997, 499, 485-496
27 Fernandez del Pozo, B., Perez-Vizcaino, F., Fernandez, C., Zaragoza, F. and Tamargo, J. Effects of several class I antiarrhythmic drugs on isolated rat aortic vascular smooth muscle. Gen. Pharmacol. 1997, 29, 539-543
28 Leung, E., Walsh, L. K., Pulido-Rios, M. T. and Eglen, R. M. Characterization of putative 5-$HT_7$ receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein. Br. J. Pharmacol. 1996, 117, 926-930
29 Ungvari, Z., Pacher, P. and Koller, A. Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [$Ca^{2+}$]i. J. Cardiovasc. Pharmacol. 2000, 35, 849-854
30 Cauvin, C., Loutzenhiser, R. and van Breemen, C. Mechanism of calcium-antagonist induced vasodilation. Annu. Rev. Pharmacol. 1983, 23, 373-396
31 Vila, J. M., Medina, P., Segarra, G., Lluch, P., Pallardo, F., Flor, B. and Lluch, S. Relaxant effects of antidepressants on human isolated mesenteric arteries. Br. J. Clin. Pharmacol. 1999, 48, 223-229
32 Pancrazio, J. J., Kamatchi, G. L., Roscoe, A. K. and Lynch, C. 3rd. Inhibition of neuronal $Na^+$ channels by antidepressant drugs. J. Pharmacol. Exp. Ther. 1998, 284, 208-214
33 Tytgat, J., Maertens, C. and Daenens, P. Effect of fluoxetine on a neuronal voltage-dependent potassium channel. Br. J. Pharmacol. 1997, 122. 1417-1424
34 Garcia-Colunga, J., Awad, J. N. and Miledi, R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. USA. 1997, 94, 2041-2044
35 McLean, P. G. and Coupar, I. M. Characterisation of a postjunctional 5-$HT_7$-like and a prejunctional 5-$HT_3$ receptor mediating contraction of rat isolated jejunum. Eur. J. Pharmacol. 1996, 312, 215-225